Mutual Funds: Prospectus Objectives - Corporate Bond - High Quality

Back to Mutual Funds Prospectus Objectives main page
Symbol
Name
Price
% Chg
% Chg YTD
ACASX Access Capital Community Investment A 9.09 +0.00% -0.11%
ACATX Access Capital Community Investment IS 9.08 +0.00% -0.11%
ACCSX Access Capital Community Investment I 9.09 +0.11% -0.11%
ADPAX AB Short Duration A 11.75 +0.00% 0.00%
ADPCX AB Short Duration C 11.72 +0.00% -0.09%
BIFIX William Blair Income I 8.63 +0.12% -0.23%
BIFJX William Blair Income R6 8.63 +0.12% -0.23%
CCBPX Capital Group Core Bond 10.46 +0.10% -0.38%
CPPAX American Funds Preservation Port 529A 10.29 +0.00% -0.19%
CPPCX American Funds Preservation Port 529C 10.28 +0.00% -0.19%
CPPEX American Funds Preservation Port 529E 10.29 +0.10% -0.10%
CPPFX American Funds Preservation Port 529F1 10.29 +0.00% -0.19%
CPPGX American Funds Preservation Port ABLE-A 10.30 +0.10% -0.10%
CPQGX American Funds Preservation ABLE-F-2 10.30 +0.10% -0.10%
DFEQX DFA Short-Term Extended Quality I 11.00 +0.00% 0.00%
DFIHX DFA One-Year Fixed-Income I 10.30 +0.00% 0.00%
DFTEX DFA Intermediate-Term Extnd Qlty I 11.87 +0.25% -0.84%
EXCIX Manning & Napier Core Bond I 10.26 +0.20% -0.68%
EXCRX Manning & Napier Core Bond S 11.20 +0.18% -0.71%
FFPPX American Funds Preservation 529-F-3 10.30 +0.10% -0.10%
FHPFX Fidelity® Series Invest Grd Securtzd 10.45 +0.00% -0.10%
FPPPX American Funds Preservation 529-F-2 10.30 +0.10% -0.10%
HOSBX Homestead Short-Term Bond 5.31 +0.00% -0.19%
IDMAX iM Dolan McEniry Corporate Bond Adv 10.88 +0.09% -0.28%
IDMIX iM Dolan McEniry Corporate Bond Instl 10.89 +0.09% -0.27%
  1. 1 - 25 of 101
  2. First
  3. Previous
  4. Next
  5. Last

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.